Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where fasc_issn='0278-0232' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 145 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jorgensen, HG; Holyoake, TL
      A comparison of normal and leukemic stem cell biology in chronic myeloid leukemia

      HEMATOLOGICAL ONCOLOGY
    2. Macheta, M; Yin, JAL
      Recent advances in the treatment of AML

      HEMATOLOGICAL ONCOLOGY
    3. Hennessy, BJ; Orchard, KH; Potter, MN
      Novel approaches to transplant conditioning

      HEMATOLOGICAL ONCOLOGY
    4. Arland, M; Leuner, S; Lange, S; Bartsch, R; Kahl, C; Florschutz, A; Franke, A; Hoffkes, HG
      Ifosfamide, epirubicin and granulocyte colony-stimulating factor: A regimen for successful mobilization of peripheral blood progenitor cells in patients with multiple myeloma

      HEMATOLOGICAL ONCOLOGY
    5. Peach, HG; Barnett, NE
      Critical review of epidemiological studies of the association between smoking and non-Hodgkin's lymphoma

      HEMATOLOGICAL ONCOLOGY
    6. Chan, WC
      The Reed-Sternberg cell in classical Hodgkin's disease

      HEMATOLOGICAL ONCOLOGY
    7. Littlewood, TJ
      Erythropoietin for the treatment of anemia associated with hematological malignancy

      HEMATOLOGICAL ONCOLOGY
    8. Mills, KI
      Differential display as an approach to study differentiation and differentiation therapy in AML

      HEMATOLOGICAL ONCOLOGY
    9. Johnson, SA; Thomas, W
      Therapeutic potential of purine analogue combinations in the treatment of lymphoid malignancies

      HEMATOLOGICAL ONCOLOGY
    10. Au, WY; Kwong, YL; Ma, SK; Mak, YK; Wong, KF; Lei, KI; Ng, MH; Chan, JCW; Lin, SY; Lee, KK; Liang, R
      Hairy cell leukemia in Hong Kong Chinese: A 12-year retrospective survey

      HEMATOLOGICAL ONCOLOGY
    11. Bentley, DP; Pepper, CJ
      The apoptotic pathway: A target for therapy in chronic lymphocytic leukemia

      HEMATOLOGICAL ONCOLOGY
    12. Das-Gupta, EP; Seedhouse, CH; Russell, NH
      DNA repair mechanisms and acute myeloblastic leukemia

      HEMATOLOGICAL ONCOLOGY
    13. Davies, FE; Rawstron, AC; Pratt, G; Coupe, R; Clarke, D; Lubenko, A; Short, K; Perren, TJ; Selby, PJ; MacLennan, S; Major, K; Woodhead, V; Robinson, F; Child, JA; Smith, GM; Johnson, PWM; Morgan, GJ
      Positive and negative selection to reduce tumour contamination in peripheral blood stem cell harvests

      HEMATOLOGICAL ONCOLOGY
    14. Owen, RG; Johnson, SA; Morgan, GJ
      Waldenstrom's macroglobulinaemia: Laboratory diagnosis and treatment

      HEMATOLOGICAL ONCOLOGY
    15. Aizawa, S; Shimizu, N; Handa, H; Hiramoto, M; Hoshi, H; Nagasu, M; Kanno, H; Nagasu, Y; Imanishi, Y
      Effects of cyclic polylactate (CPL) on the growth of cloned leukemic cellsin vitro

      HEMATOLOGICAL ONCOLOGY
    16. Conconi, A; Zucca, E; Roggero, E; Bertoni, F; Bernasconi, A; Mingrone, W; Pedrinis, E; Cavalli, F
      Prognostic models for diffuse large B-cell lymphoma

      HEMATOLOGICAL ONCOLOGY
    17. Dierlamm, J; Wlodarska, I; Michaux, L; Stefanova, M; Hinz, K; Van den Berghe, H; Hagemeijer, A; Hossfeld, DK
      Genetic abnormalities in marginal zone B-cell lymphoma

      HEMATOLOGICAL ONCOLOGY
    18. Bertoni, F; Sanna, P; Tinguely, M; Roggero, E; Conconi, A; Gisi, M; Cazzaniga, G; Biondi, A; Pedrinis, E; Cavalli, F; Zucca, E
      Association of gastric and Waldeyer's ring lymphoma: A molecular study

      HEMATOLOGICAL ONCOLOGY
    19. Pels, H; Deckert-Schluter, M; Glasmacher, A; Kleinschmidt, R; Oehring, R; Fischer, HP; Bode, U; Schlegel, U
      Primary central nervous system lymphoma: A clinicopathological study of 28cases

      HEMATOLOGICAL ONCOLOGY
    20. Skinnider, BF; Connors, JM; Sutcliffe, SB; Gascoyne, RD
      Anaplastic large cell lymphoma: A clinicopathologic analysis

      HEMATOLOGICAL ONCOLOGY
    21. Liu, AC; Takahashi, M; Toba, K; Zheng, ZY; Hashimoto, S; Nikkuni, K; Furukawa, T; Koike, T; Aizawa, Y
      Regulation of the expression of MHC class I and II by class II transactivator (CIITA) in hematopoietic cells

      HEMATOLOGICAL ONCOLOGY
    22. Yokota, A; Ishii, G; Sugaya, Y; Nishimura, M; Saito, Y; Harigaya, K
      Potential use of serum CD44 as an indicator of tumour progression in acuteleukemia

      HEMATOLOGICAL ONCOLOGY
    23. Ma, SK; Wan, TSK; Chan, LC
      Cytogenetics and molecular genetics of childhood leukemia

      HEMATOLOGICAL ONCOLOGY
    24. Jelic, S; Filipovic-Ljeskovic, I
      Positive serology for Lyme disease Borrelias in primary cutaneous B-cell lymphoma: A study in 22 patients; Is it a fortuitous finding?

      HEMATOLOGICAL ONCOLOGY
    25. Ho, JWY; Liang, RHS; Srivastava, G
      Preferential type1-1 cytokine gene expressions in peripheral T-cell lymphomas

      HEMATOLOGICAL ONCOLOGY
    26. Au, WY; Kwong, YL; Lie, AKW; Ma, SK; Liang, R
      Extra-medullary relapse of leukemia following allogeneic bone marrow transplantation

      HEMATOLOGICAL ONCOLOGY
    27. Young, GAR
      Lymphoma at uncommon sites

      HEMATOLOGICAL ONCOLOGY

    28. Recent publications in hematological oncology

      HEMATOLOGICAL ONCOLOGY
    29. Simone, MD; De Santis, S; Vigneti, E; Papa, G; Amadori, S; Aloe, L
      Nerve growth factor: A survey of activity on immune and hematopoietic cells

      HEMATOLOGICAL ONCOLOGY
    30. Vidal, C; Baer, MR; Bloomfield, CD
      Uncommon patterns of presentation of leukemia (Reprinted from Textbook of Uncommon Cancer Second Edition)

      HEMATOLOGICAL ONCOLOGY
    31. Cartwright, RA; Gilman, EA; Nicholson, P; Allon, D
      Epidemiology of multiple myeloma in parts of England, 1984-1993

      HEMATOLOGICAL ONCOLOGY
    32. TIRELLI U; ZAGONEL V; ERRANTE D; FRATINO L; MONFARDINI S
      TREATMENT OF NON-HODGKINS-LYMPHOMA IN THE ELDERLY - AN UPDATE

      Hematological oncology
    33. CANZONIERI V; CARBONE A
      CLINICAL AND BIOLOGICAL APPLICATIONS OF IMAGE-ANALYSIS IN NON-HODGKINS-LYMPHOMAS

      Hematological oncology
    34. POPESCU RA; WOTHERSPOON AC; CUNNINGHAM D
      LOCAL RECURRENCE OF A PRIMARY PANCREATIC LYMPHOMA 18 YEARS AFTER COMPLETE REMISSION

      Hematological oncology
    35. KANDA Y; KAMI M; MATSUYAMA T; MITANI K; CHIBA S; YAZAKI Y; HIRAI H
      PLASMA-CONCENTRATION OF ITRACONAZOLE IN PATIENTS RECEIVING CHEMOTHERAPY FOR HEMATOLOGICAL MALIGNANCIES - THE EFFECT OF FAMOTIDINE ON THE ABSORPTION OF ITRACONAZOLE

      Hematological oncology
    36. Yokota, A; Ishii, G; Sugaya, Y; Nishimura, M; Saito, Y; Harigaya, K
      Expression of exon v6-containing CD44 isoforms is related to poor prognosis of acute myelocytic leukemia

      HEMATOLOGICAL ONCOLOGY
    37. Anand, M; Chodda, SK; Parikh, PM; Nadkarni, JS
      Abnormal levels of proinflammatory cytokines in serum and monocyte cultures from patients with chronic myeloid leukemia in different stages, and their role in prognosis

      HEMATOLOGICAL ONCOLOGY
    38. Arslan, O; Ustun, C; Arat, M; Celebi, H; Akan, H; Beksac, M; Ilhan, O; Gurman, G; Ozcan, M; Konuk, N; Uysal, A; Koc, H
      Allogeneic peripheral blood stem cell transplantation in acute non-lymphoblastic leukemia

      HEMATOLOGICAL ONCOLOGY
    39. Au, WY; Lie, AKW; Ma, SK; Chan, LC; Lee, CK; Kwong, YL; Chim, CS; Chan, TK; Chiu, E; Liang, R
      Allogeneic bone marrow transplantation for adult acute lymphoblastic leukemia: A single-centre experience

      HEMATOLOGICAL ONCOLOGY
    40. Hoyle, CF; Negrin, RS
      Engraftment of chronic myeloid leukemia in SCID mice

      HEMATOLOGICAL ONCOLOGY
    41. Rule, S; Tighe, M; Davies, S; Johnson, S
      Vinorelbine in the treatment of lymphoma

      HEMATOLOGICAL ONCOLOGY
    42. Emmanouilides, C; Rosen, P; Rasti, S; Territo, B; Kunkel, L
      Treatment of indolent lymphoma with fludarabine/mitoxantrone combination: A phase II trial

      HEMATOLOGICAL ONCOLOGY
    43. Chim, CS; Kwong, YL; Lie, AKW; Lee, CK; Liang, R
      CEOP treatment results and validity of the international prognostic index in Chinese patients with aggressive non-Hodgkin's lymphoma

      HEMATOLOGICAL ONCOLOGY
    44. Au, WY; Lie, AKW; Kwong, YL; Chan, TK; Chim, CS; Lee, CK; Chiu, EKW; Liang, R
      Allogeneic bone marrow transplantation for severe aplastic anemia: The Hong Kong scenario

      HEMATOLOGICAL ONCOLOGY
    45. Pratt, G; Wiles, ME; Rawstron, AC; Davies, FE; Fenton, JAL; Proffitt, JA; Child, JA; Smith, GM; Morgan, GJ
      Liposomal daunorubicin: In vitro and in vivo efficacy in multiple myeloma

      HEMATOLOGICAL ONCOLOGY
    46. Aizawa, S; Hiramoto, M; Araki, S; Negishi, S; Kimura, Y; Hoshi, H; Kojima, S; Wakasugi, K
      Stimulatory effects of neopterin on hematopoiesis in vitro are mediated byactivation of stromal cell function

      HEMATOLOGICAL ONCOLOGY
    47. Auer, RL; Holtom, P; Smith, H; Fegan, CD; Milligan, DW
      Circulating CD34(+) counts and apheresis planning

      HEMATOLOGICAL ONCOLOGY
    48. JOX A; WOLF J; DIEHL V
      HODGKINS-DISEASE BIOLOGY - RECENT ADVANCES

      Hematological oncology
    49. MCNALLY RJQ; ROWLAND D; ROMAN E; CARTWRIGHT RA
      AGE AND SEX DISTRIBUTIONS OF HEMATOLOGICAL MALIGNANCIES IN THE UK

      Hematological oncology
    50. CHETTY R; BICKHOO A
      RETINOBLASTOMA PROTEIN AND EPSTEIN-BARR-VIRUS (EBV) EXPRESSION IN SOUTH-AFRICAN HODGKINS-DISEASE

      Hematological oncology
    51. SCHMITTER D; KOSS M; NIEDERER E; STAHEL RA; PICHERT G
      T-CELL DERIVED CYTOKINES CO-STIMULATE PROLIFERATION OF CD40-ACTIVATEDGERMINAL CENTER AS WELL AS FOLLICULAR LYMPHOMA-CELLS

      Hematological oncology
    52. HIGUCHI T; SHIMIZU T; MORI H; NIIKURA H; OMINE M
      COAGULATION PATTERNS OF DISSEMINATED INTRAVASCULAR COAGULATION IN ACUTE PROMYELOCYTIC LEUKEMIA

      Hematological oncology
    53. NAGAI M; FUJITA M; OHMORI M; MATSUBARA S; TANIWAKI M; HORIIKE S; TASAKA T; KOEFFLER HP; TAKAHARA J
      ESTABLISHMENT OF A NOVEL HUMAN B-CELL LINE (OZ) WITH T(14-18)(Q32-Q21) AND ABERRANT P53 EXPRESSION WAS ASSOCIATED WITH THE HOMOZYGOUS DELETIONS OF P15(INK4B) AND P16(INK4A) GENES

      Hematological oncology
    54. BAIREY O; GABBAY U; BLICKSTEIN D; STARK P; PROKOCIMER M; EPSTEIN O; SHAKLAI M; LAHAV J
      LEVELS OF PROTEIN-C AND PROTEIN-S DO NOT DECLINE SUBSEQUENT TO FIRST-LINE CHEMOTHERAPY IN LYMPHOMA PATIENTS

      Hematological oncology
    55. SCHULTZE JL
      VACCINATION AS IMMUNOTHERAPY FOR B-CELL LYMPHOMA

      Hematological oncology
    56. MA SK; CHAN GCF; HA SY; CHIU DCK; LAU YL; CHAN LC
      CLINICAL PRESENTATION, HEMATOLOGIC FEATURES AND TREATMENT OUTCOME OF CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA - A REVIEW OF 73 CASES IN HONG-KONG

      Hematological oncology
    57. EZAWA H; HARIGAYA K; ISHII G; NAKAJIMA N; MIKATA A
      12-O-TETRADECANOYLPHORBOL-13-ACETATE (TPA) DOWN-REGULATES EXPRESSION OF CD30 IN ERYTHROLEUKEMIA CELL-LINE K562

      Hematological oncology
    58. JELIC S; FRIM O; GLIGORIJEVIC G; GAVRILOVIC D; MANOJLOVIC N; JOVANOVIC V; OPRIC M
      A CONTROVERSIAL ISSUE - COULD A WATCH-AND-WAIT POLICY FOR PATIENTS WITH NON-HODGKINS-LYMPHOMA CLINICAL STAGE-I OR IE WITH NO LYMPHOMA LEFT FOLLOWING DIAGNOSTIC SURGERY BE JUSTIFIED - RESULTS OF A SINGLE-CENTERSTUDY

      Hematological oncology
    59. SMITH JL; HODGES E; QUIN CT; WRIGHT DH
      MOLECULAR-DETECTION OF A B-CELL CLONE IN A CASE OF PTCL IN THE ABSENCE OF T-CELL CLONALITY

      Hematological oncology
    60. KWONG YL; CHAN ACL; LIANG RHS
      NATURAL-KILLER-CELL LYMPHOMA LEUKEMIA - PATHOLOGY AND TREATMENT/

      Hematological oncology
    61. LIMA M; TEIXEIRA MD; DOSSANTOS AHR; QUEIROS ML; JUSTICA B
      DECREASED EXPRESSION OF BCL-2 (P26) IN CD8((-CELL LYMPHOPROLIFERATIVEDISORDERS OF LARGE GRANULAR LYMPHOCYTES()) LYMPHOCYTES OF PATIENTS WITH T)

      Hematological oncology
    62. MA SK; AU WY; KWONG YL; LAM CK; LIANG RHS; CHAN LC
      HEMATOLOGICAL FEATURES AND TREATMENT OUTCOME IN ACUTE MYELOID-LEUKEMIA WITH T(8-21)

      Hematological oncology
    63. COTTER FE
      ANTISENSE THERAPY FOR LYMPHOMAS

      Hematological oncology
    64. CULL GM; EIKELBOOM JW; CANNELL PK
      EXACERBATION OF COAGULOPATHY WITH CONCURRENT BONE-MARROW NECROSIS, HEPATIC AND RENAL DYSFUNCTION SECONDARY TO ALL-TRANS-RETINOIC ACID THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA

      Hematological oncology
    65. CHIM CS; KWONG YL; CHU YC; CHAN CH; CHAN YT; LIANG R
      IMPROVED TREATMENT OUTCOME IN ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA USING THE INTENSIVE GERMAN PROTOCOL, - A PRELIMINARY-REPORT

      Hematological oncology
    66. CARACCIOLO F; CAPOCHIANI E; PAPINESCHI F; PETRINI M
      A NEW EFFECTIVE TREATMENT FOR INDOLENT LYMPHOMA - A PILOT-STUDY WITH FLUDARABINE, IDARUBICIN AND PREDNISONE COMBINATION (FLIDA)

      Hematological oncology
    67. AU WY; CHAN ACL; CHOW LWC; LIANG R
      LYMPHOMA OF THE BREAST IN HONG-KONG CHINESE

      Hematological oncology
    68. RANDHAWA PS; PIETRZAK B; NALESNIK MA; DEMETRIS AJ; LOCKER J
      SUBCUTANEOUS IMPLANTATION OF HUMAN POSTTRANSPLANT LYMPHOPROLIFERATIVEDISEASE LESIONS IN SCID MICE

      Hematological oncology
    69. BIRD G; PEEL D; MCCARTHY K; WILLIAMS H
      EPSTEIN-BARR-VIRUS INDUCED VIRUS-ASSOCIATED HEMOPHAGOCYTIC SYNDROME AND MONOCLONAL TCR-BETA REARRANGEMENT - A CASE-REPORT

      Hematological oncology
    70. CORTI C; THEODORE C; BAYLE C; ROUGIER P; NASR F; COSSET JM; GIRINSKY T; HAYAT M; RIBRAG V
      HIGH-INCIDENCE OF SECONDARY MYELODYSPLASTIC SYNDROMES FOLLOWING PROMACE-MOPP AND INVOLVED FIELD RADIOTHERAPY FOR LOCALIZED GASTRIC NON-HODGKINS-LYMPHOMAS

      Hematological oncology
    71. ZAPATERO A; MARIN A; LOPEZ M; DEVIDALES CM; CEREZO L; DOMINGUEZ P; TORRUBIA AP
      SUCCESSFUL BONE-MARROW TRANSPLANTATION IN SENSITIZED APLASTIC-ANEMIA PATIENTS USING TOTAL LYMPHOID IRRADIATION FOR CONDITIONING - LONG-TERMFOLLOW-UP

      Hematological oncology
    72. CHIM CS; LIANG R; CHAN ACL; KWONG YL; HO FCS; TODD D
      PRIMARY B-CELL LYMPHOMA OF THE MEDIASTINUM

      Hematological oncology
    73. TAI GX; JUNG EY; YUJI H; MASAHIKO K; TOSHIO H; KENJI K; KENSHI F; MITSUFUMI M
      DIFFERENT EFFECTS OF CYCLIC-AMP AND BUTYRATE ON EOSINOPHILIC DIFFERENTIATION, APOPTOSIS AND BCL-2 EXPRESSION OF A HUMAN EOSINOPHILIC LEUKEMIA-CELL LINE, EOL-1

      Hematological oncology
    74. SMITH GM; CHILD JA; CULLEN MH; BAILEY NP; WOODRUFFE CM; FLETCHER J; EARL H; BARNARD D
      A PHASE-I TRIAL TO ASSESS THE VALUE OF RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR (R-METHUG-CSF, FILGRASTIM) IN ACCELERATING THE DOSE-RATE OF CHEMOTHERAPY FOR INTERMEDIATE AND HIGH-GRADE NON-HODGKINS-LYMPHOMA (NHL)

      Hematological oncology
    75. AVILES A; HUERTAGUZMAN J; DELGADO S; FERNANDEZ A; DIAZMAQUEO JC
      IMPROVED OUTCOME IN SOLITARY BONE PLASMACYTOMAS WITH COMBINED THERAPY

      Hematological oncology
    76. LIPTON JH; DERZKO CM; CURTIS J
      ALPHA-INTERFERON AND PREGNANCY IN A PATIENT WITH CML

      Hematological oncology
    77. OHSHIMA K; SUZUMIYA J; MUKAI Y; TASHIRO K; SHIBATA T; TANAKA T; KATO A; KIKUCHI M
      CLASSICAL HODGKIN AND REED-STERNBERG CELLS DEMONSTRATE A NON-CLONAL IMMATURE B-LYMPHOID LINEAGE - EVIDENCE FROM A SINGLE-CELL ASSAY AND IN-SITU HYBRIDIZATION

      Hematological oncology
    78. LEVEQUE E; NAGEL MD; HAYE B
      EFFECT OF THE INTERACTION BETWEEN TRANSFORMING GROWTH-FACTOR-BETA ANDERYTHROPOIETIN ON THE PROLIFERATION OF NORMAL ERYTHROID PROGENITORS AND LEUKEMIC UT-7 CELLS - ACTION OF TRANSFORMING GROWTH-FACTOR-BETA ON THE ERYTHROPOIETIN RECEPTOR

      Hematological oncology
    79. CHIM CS; KWONG YL; LIANG R; CHU YC; CHAN CH; CHAN LC; WONG KF; CHAN TK
      ALL-TRANS-RETINOIC ACID (ATRA) IN THE TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA (APL)

      Hematological oncology
    80. CHAN DW; LIANG R; KWONG YL
      PATTERN OF T-CELL RECEPTOR DELTA-GENE REARRANGEMENT BY SOUTHERN BLOTTING AND POLYMERASE CHAIN-REACTION TECHNIQUE IN HONG-KONG CHINESE PATIENTS WITH NON-T-CELL HEMATOLOGICAL MALIGNANCIES

      Hematological oncology
    81. FLAVELL DJ
      MODELING HUMAN LEUKEMIA AND LYMPHOMA IN SEVERE COMBINED IMMUNODEFICIENT (SCID) MICE - PRACTICAL APPLICATIONS

      Hematological oncology
    82. BRAUN MG; CSERNOK E; ROGENERSCHWARZ W; LUDWIG WD; MULLERHERMELINK HK; GROSS WL; FELLER AC
      MONOCLONAL-ANTIBODY WGM1 DIRECTED AGAINST PROTEINASE-3 - AN IMMUNOHISTOCHEMICAL MARKER FOR NAPHTHOL ASD CHLOROACETATE

      Hematological oncology
    83. OHSHIMA K; HASHIMOTO K; IZUMO S; SUZUMIYA J; KIKUCHI M
      DETECTION OF HUMAN T-LYMPHOTROPHIC VIRUS TYPE-I (HTLV-I) DNA AND MESSENGER-RNA IN INDIVIDUAL CELLS BY POLYMERASE CHAIN-REACTION (PCR) IN-SITU HYBRIDIZATION (ISH) AND REVERSE TRANSCRIPTION (RT)-PCR ISH

      Hematological oncology
    84. LIANG R; TODD D; HO FCS
      AGGRESSIVE NON-HODGKINS-LYMPHOMA - T-CELL VERSUS B-CELL

      Hematological oncology
    85. TIRELLI U; ERRANTE D; SPINA M; VACCHER E; SERRAINO D; BOIOCCHI M; GLOGHINI A; CARBONE A
      LONG-TERM SURVIVAL OF PATIENTS WITH HIV-RELATED SYSTEMIC NON-HODGKINS-LYMPHOMAS

      Hematological oncology
    86. HARDY CL; MEGASON GC
      SPECIFICITY OF HEMATOPOIETIC STEM-CELL HOMING

      Hematological oncology
    87. LIPTON JH; GOSPODAROWICZ M; REINGOLD S
      ACUTE MYELOID-LEUKEMIA FOLLOWING THERAPY OF HODGKINS-DISEASE WITH RADIOTHERAPY AND ABVD (DOXORUBICIN, BLEOMYCIN, VINBLASTINE, AND DACARBAZINE)

      Hematological oncology
    88. MAHENDRA P; HOOD IM; BASS G; PATTERSON P; MARCUS RE
      SEVERE HEMOSIDEROSIS POST ALLOGENEIC BONE-MARROW TRANSPLANTATION

      Hematological oncology
    89. CLEMONS MJ; WILLIAMS YF; GOLDMAN JM; BARRETT AJ
      LONG-TERM CONTROL OF POLYCYTHEMIA RUBRA VERA WITH RECOMBINANT ALPHA-INTERFERON

      Hematological oncology
    90. DONEDA L; BIONDI A; RAMBALDI A; LARIZZA L
      IDENTIFICATION OF CHROMOSOMAL REARRANGEMENTS IN THE HUMAN MYELOID-LEUKEMIA CELL-LINE GF-D8 BY DUAL-COLOR FLUORESCENCE IN-SITU HYBRIDIZATION

      Hematological oncology
    91. FLAVELL DJ; COOPER S; OKAYAMA K; EMERY L; FLAVELL SU
      COMPARISON OF THE PERFORMANCE OF ANTI-CD7 AND ANTI-CD38 BISPECIFIC ANTIBODIES AND IMMUNOTOXINS FOR THE DELIVERY OF SAPORIN TO A HUMAN T-CELL ACUTE LYMPHOBLASTIC-LEUKEMIA CELL-LINE

      Hematological oncology
    92. JANUSZKIEWICZ DA; NOWAK JS
      MOLECULAR EVIDENCE FOR CENTRAL-NERVOUS-SYSTEM INVOLVEMENT IN CHILDRENWITH NEWLY-DIAGNOSED ACUTE LYMPHOBLASTIC-LEUKEMIA

      Hematological oncology
    93. ERLANSON M; LINDH J; ZACKRISSON B; LANDBERG G; ROOS G
      CELL KINETIC-ANALYSIS OF NON-HODGKINS-LYMPHOMAS USING IN-VIVO IODODEOXYURIDINE INCORPORATION AND FLOW-CYTOMETRY

      Hematological oncology
    94. CLARK RE; PENDER N
      TRANSPLANTATION OF T-LYMPHOCYTE DEPLETED MARROW WITH AN ADDBACK OF T-CELLS

      Hematological oncology
    95. KLEIN SC; JUCKER M; ABTS H; TESCH H
      IL6 AND IL6 RECEPTOR EXPRESSION IN BURKITTS-LYMPHOMA AND LYMPHOBLASTOID CELL-LINES - PROMOTION OF IL6 RECEPTOR EXPRESSION BY EBV

      Hematological oncology
    96. RATCLIFFE MA; GILBERT FJ; DAWSON AA; BENNETT B
      DIAGNOSIS OF AVASCULAR NECROSIS OF THE FEMORAL-HEAD IN PATIENTS TREATED FOR LYMPHOMA

      Hematological oncology
    97. RUBIOFELIX D; GIRALDO P; FRANCO E; GIMENO J; GIRALT M
      PROGNOSTIC FACTORS IN MYELODYSPLASTIC SYNDROMES - ANALYSIS OF 5 SCORING SYSTEMS

      Hematological oncology
    98. LIANG R; TODD D; CHAN TK; CHIU E; LIE A; KWONG YL; CHOY D; HO FCS
      PROGNOSTIC FACTORS FOR PRIMARY GASTROINTESTINAL LYMPHOMA

      Hematological oncology

    99. CURRENT-AWARENESS IN HEMATOLOGICAL ONCOLOGY

      Hematological oncology
    100. DIAZPAVON JR; PUGH W; CABANILLAS F
      SIMULTANEOUS PRESENTATION OF HAIRY-CELL LEUKEMIA AND FOLLICULAR SMALLCLEAVED CELL LYMPHOMA IN A PATIENT WITH PREVIOUS DIAGNOSIS OF RENAL-CELL CARCINOMA

      Hematological oncology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 20/01/21 alle ore 23:50:53